MeSH Review:
Area Under Curve
Hughes,
Calvert,
Azzabi,
Plummer,
Johnson,
Rusthoven,
Griffin,
Fishwick,
Boddy,
Verrill,
Calvert,
Pagel,
Appelbaum,
Eary,
Rajendran,
Fisher,
Gooley,
Ruffner,
Nemecek,
Sickle,
Durack,
Carreras,
Horowitz,
Press,
Gopal,
Martin,
Bernstein,
Matthews,
Gore,
Mainwaring,
A'Hern,
MacFarlane,
Slevin,
Harper,
Osborne,
Mansi,
Blake,
Wiltshaw,
Shepherd,
Lau,
Leigh,
Gandara,
Edelman,
Morgan,
Israel,
Lara,
Wilder,
Ryu,
Doroshow,
Hayden,
Jennings,
Robson,
Schiff,
Jackson,
Rana,
McClelland,
Ipe,
Roberts,
Ward,
Balis,
Holcenberg,
Poplack,
Ge,
Sather,
Murphy,
Ames,
Waskerwitz,
Tubergen,
Zimm,
Gilchrist,
Bleyer,
- Phase I study of escalating targeted doses of carboplatin combined with ifosfamide and etoposide in treatment of newly diagnosed pediatric solid tumors. Marina, N.M., Rodman, J.H., Murry, D.J., Shema, S.J., Bowman, L.C., Jones, D.P., Furman, W., Meyer, W.H., Pratt, C.B. J. Natl. Cancer Inst. (1994)
- Insulin, intact and split proinsulin, and coronary artery disease in young men. Båvenholm, P., Proudler, A., Tornvall, P., Godsland, I., Landou, C., de Faire, U., Hamsten, A. Circulation (1995)
- A phase I study of an anti-CD22-deglycosylated ricin A chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy. Amlot, P.L., Stone, M.J., Cunningham, D., Fay, J., Newman, J., Collins, R., May, R., McCarthy, M., Richardson, J., Ghetie, V. Blood (1993)
- 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Pagel, J.M., Appelbaum, F.R., Eary, J.F., Rajendran, J., Fisher, D.R., Gooley, T., Ruffner, K., Nemecek, E., Sickle, E., Durack, L., Carreras, J., Horowitz, M.M., Press, O.W., Gopal, A.K., Martin, P.J., Bernstein, I.D., Matthews, D.C. Blood (2006)
- Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer. Krigel, R.L., Palackdharry, C.S., Padavic, K., Haas, N., Kilpatrick, D., Langer, C., Comis, R. J. Clin. Oncol. (1994)
- The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Willert, R.P., Woolf, C.J., Hobson, A.R., Delaney, C., Thompson, D.G., Aziz, Q. Gastroenterology (2004)
- Effect of inhaled heparin on allergen-induced early and late asthmatic responses in patients with atopic asthma. Diamant, Z., Timmers, M.C., van der Veen, H., Page, C.P., van der Meer, F.J., Sterk, P.J. Am. J. Respir. Crit. Care Med. (1996)
- Neuropsychological change and S-100 protein release in 130 unselected patients undergoing cardiac surgery. Kilminster, S., Treasure, T., McMillan, T., Holt, D.W. Stroke (1999)
- Increasing correlations between personality traits and cortisol stress responses obtained by data aggregation. Pruessner, J.C., Gaab, J., Hellhammer, D.H., Lintz, D., Schommer, N., Kirschbaum, C. Psychoneuroendocrinology (1997)
- Oral androstenedione administration and serum testosterone concentrations in young men. Leder, B.Z., Longcope, C., Catlin, D.H., Ahrens, B., Schoenfeld, D.A., Finkelstein, J.S. JAMA (2000)
- Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial. Hadigan, C., Corcoran, C., Basgoz, N., Davis, B., Sax, P., Grinspoon, S. JAMA (2000)
- The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.P., von Richter, O., Zundler, J., Kroemer, H.K. J. Clin. Invest. (1999)
- Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Kishi, S., Yang, W., Boureau, B., Morand, S., Das, S., Chen, P., Cook, E.H., Rosner, G.L., Schuetz, E., Pui, C.H., Relling, M.V. Blood (2004)
- Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. Vokes, E.E., Ratain, M.J., Mick, R., McEvilly, J.M., Haraf, D., Kozloff, M., Hamasaki, V., Weichselbaum, R.R., Panje, W.R., Wenig, B. J. Clin. Oncol. (1993)
- Limited sampling models for doxorubicin pharmacokinetics. Ratain, M.J., Robert, J., van der Vijgh, W.J. J. Clin. Oncol. (1991)
- Predicting etoposide toxicity: relationship to organ function and protein binding. Joel, S.P., Shah, R., Clark, P.I., Slevin, M.L. J. Clin. Oncol. (1996)
- Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer. Iaffaioli, R.V., Tortoriello, A., Facchini, G., Caponigro, F., Gentile, M., Marzano, N., Gravina, A., Dimitri, P., Costagliola, G., Ferraro, A., Ferrante, G., De Marino, V., Illiano, A. J. Clin. Oncol. (1999)
- Preclinical and phase I studies with rhizoxin to apply a pharmacokinetically guided dose-escalation scheme. Graham, M.A., Bissett, D., Setanoians, A., Hamilton, T., Kerr, D.J., Henrar, R., Kaye, S.B. J. Natl. Cancer Inst. (1992)
- Oral oseltamivir in human experimental influenza B infection. Hayden, F.G., Jennings, L., Robson, R., Schiff, G., Jackson, H., Rana, B., McClelland, G., Ipe, D., Roberts, N., Ward, P. Antivir. Ther. (Lond.) (2000)
- Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy. Gandhi, V., Estey, E., Keating, M.J., Plunkett, W. J. Clin. Oncol. (1993)
- Phase I and pharmacokinetic study of brequinar sodium (NSC 368390). Noe, D.A., Rowinsky, E.K., Shen, H.S., Clarke, B.V., Grochow, L.B., McGuire, W.B., Hantel, A., Adams, D.B., Abeloff, M.D., Ettinger, D.S. Cancer Res. (1990)
- Pharmacokinetics and pharmacodynamics of oral methotrexate and mercaptopurine in children with lower risk acute lymphoblastic leukemia: a joint children's cancer group and pediatric oncology branch study. Balis, F.M., Holcenberg, J.S., Poplack, D.G., Ge, J., Sather, H.N., Murphy, R.F., Ames, M.M., Waskerwitz, M.J., Tubergen, D.G., Zimm, S., Gilchrist, G.S., Bleyer, W.A. Blood (1998)
- Phase I/pharmacokinetic reevaluation of thioTEPA. O'Dwyer, P.J., LaCreta, F., Engstrom, P.F., Peter, R., Tartaglia, L., Cole, D., Litwin, S., DeVito, J., Poplack, D., DeLap, R.J. Cancer Res. (1991)
- Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. Gore, M., Mainwaring, P., A'Hern, R., MacFarlane, V., Slevin, M., Harper, P., Osborne, R., Mansi, J., Blake, P., Wiltshaw, E., Shepherd, J. J. Clin. Oncol. (1998)
- Chemosensitivity testing of human colorectal carcinoma cell lines using a tetrazolium-based colorimetric assay. Park, J.G., Kramer, B.S., Steinberg, S.M., Carmichael, J., Collins, J.M., Minna, J.D., Gazdar, A.F. Cancer Res. (1987)
- Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer. Schilsky, R.L., Choi, K.E., Grayhack, J., Grimmer, D., Guarnieri, C., Fullem, L. J. Clin. Oncol. (1990)
- Phase I trial of granulocyte-macrophage colony-stimulating factor plus high-dose cyclophosphamide given every 2 weeks: a Cancer and Leukemia Group B study. Lichtman, S.M., Ratain, M.J., Van Echo, D.A., Rosner, G., Egorin, M.J., Budman, D.R., Vogelzang, N.J., Norton, L., Schilsky, R.L. J. Natl. Cancer Inst. (1993)
- Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans-retinoic acid, and its modulation by ketoconazole. Rigas, J.R., Francis, P.A., Muindi, J.R., Kris, M.G., Huselton, C., DeGrazia, F., Orazem, J.P., Young, C.W., Warrell, R.P. J. Natl. Cancer Inst. (1993)
- Lack of ranitidine effects on cyclophosphamide bone marrow toxicity or metabolism: a placebo-controlled clinical trial. Alberts, D.S., Mason-Liddil, N., Plezia, P.M., Roe, D.J., Dorr, R.T., Struck, R.F., Phillips, J.G. J. Natl. Cancer Inst. (1991)
- Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine: pharmacodynamic evaluation of carmustine. Jones, R.B., Matthes, S., Shpall, E.J., Fisher, J.H., Stemmer, S.M., Dufton, C., Stephens, J.K., Bearman, S.I. J. Natl. Cancer Inst. (1993)
- Facilitated interaction between the pyruvate dehydrogenase kinase isoform 2 and the dihydrolipoyl acetyltransferase. Hiromasa, Y., Roche, T.E. J. Biol. Chem. (2003)
- The complete nucleotide sequence, gene organization, and genetic code of the mitochondrial genome of Paracentrotus lividus. Cantatore, P., Roberti, M., Rainaldi, G., Gadaleta, M.N., Saccone, C. J. Biol. Chem. (1989)
- The role of the AUU initiation codon in the negative feedback regulation of the gene for translation initiation factor IF3 in Escherichia coli. Sacerdot, C., Chiaruttini, C., Engst, K., Graffe, M., Milet, M., Mathy, N., Dondon, J., Springer, M. Mol. Microbiol. (1996)
- The decrease in growth hormone (GH) response after repeated stimulation with GH-releasing hormone is partly caused by an elevation of somatostatin tonus. Reichardt, B., Schrader, M., Mojto, J., Mehltretter, G., Müller, O.A., Schopohl, J. J. Clin. Endocrinol. Metab. (1996)
- Effect of plasma osmolality on pituitary-adrenal responses to corticotropin-releasing hormone and atrial natriuretic peptide changes in central diabetes insipidus. Elias, L.L., Antunes-Rodrigues, J., Elias, P.C., Moreira, A.C. J. Clin. Endocrinol. Metab. (1997)
- Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model. Ehninger, G., Schuler, U., Renner, U., Ehrsam, M., Zeller, K.P., Blanz, J., Storb, R., Deeg, H.J. Blood (1995)
- Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial. Lau, D., Leigh, B., Gandara, D., Edelman, M., Morgan, R., Israel, V., Lara, P., Wilder, R., Ryu, J., Doroshow, J. J. Clin. Oncol. (2001)
- Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. Hughes, A., Calvert, P., Azzabi, A., Plummer, R., Johnson, R., Rusthoven, J., Griffin, M., Fishwick, K., Boddy, A.V., Verrill, M., Calvert, H. J. Clin. Oncol. (2002)
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function. Calvert, A.H., Newell, D.R., Gumbrell, L.A., O'Reilly, S., Burnell, M., Boxall, F.E., Siddik, Z.H., Judson, I.R., Gore, M.E., Wiltshaw, E. J. Clin. Oncol. (1989)
- Pharmacologic variables associated with the development of neurologic toxicity in patients treated with suramin. Bitton, R.J., Figg, W.D., Venzon, D.J., Dalakas, M.C., Bowden, C., Headlee, D., Reed, E., Myers, C.E., Cooper, M.R. J. Clin. Oncol. (1995)